| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.38 | 0.03 |